mConsent to Resell iCoreRx Cloud ePrescribing Solution by iCoreConnect

Core Insights - iCoreConnect Inc. has entered into a reseller agreement with mConsent to enhance its patient engagement platform by integrating iCoreRx ePrescribing software [1][2][3] - The partnership aims to provide dental practices with advanced ePrescribing solutions that streamline workflows and improve patient safety [2][4] - iCoreRx is recognized for its user-friendly interface, compliance with ePrescribing regulations, and features like real-time drug interaction checks [3][4] Company Overview - iCoreConnect Inc. is a cloud-based software and technology company focused on increasing workflow productivity and profitability in healthcare [4] - The company offers a platform of 16 SaaS enterprise solutions and has over 130 product endorsements from healthcare associations across the U.S. [4] - mConsent is a rapidly growing SaaS platform for dental practices, serving over 5 million patients and emphasizing automation to enhance patient experiences [5] Financial Impact - Dental practices using mConsent's platform save approximately $65,000 annually on administrative costs and reduce documentation time by 35% [5] - The collaboration is expected to enhance operational efficiency and patient care in dental practices [4][5]